Skip to main content
. Author manuscript; available in PMC: 2019 Apr 4.
Published in final edited form as: Clin Cancer Res. 2013 Apr 15;19(11):3095–3104. doi: 10.1158/1078-0432.CCR-13-0109

Figure 2.

Figure 2.

Number of doses of romidepsin during which replacement of magnesium or potassium or both electrolytes was required per protocol. Only 619 doses (45%) did not require potassium or magnesium replacement.